David Vernick, MD
Otolaryngology · Chestnut Hill, MANPI 1710926803
Payments from drug & device makers
Across 13 payments — averaging $25.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$52
- Neurent Medical Limited$50
- Optinose US, Inc.$45
- Integra Lifesciences Corporation$38
- Stryker$36
- Regeneron Healthcare Solutions, Inc.$29
- plus $77 from 4 others
What the payments were for
- Food & beverage$327100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 2 | $52 |
| Neurent Medical Limited | 2 | $50 |
| Optinose US, Inc. | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $38 |
| Stryker | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Sanofi | 1 | $23 |
| Aerin Medical Inc. | 1 | $20 |
| Intersect ENT, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $15 |
How this compares
$327 in reported general payments places this provider in the 40th percentile of 298 otolaryngology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 158 | $6,428 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 102 | $6,031 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 31 | $3,280 |
| Fluticasone Propionate | 162 | $3,068 |
| Omeprazole | 71 | $821 |
| Triamcinolone Acetonide | 97 | $365 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $281 |
| Famotidine | 14 | $264 |
| Ofloxacin | 14 | $189 |
| Hydrochlorothiazide | 31 | $114 |
| Mupirocin | 17 | $103 |
| Methylprednisolone | 17 | $92 |
| Ciprofloxacin Hcl | 12 | $55 |
| Prednisone | 11 | $43 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Chestnut Hill
- Harsha Girdhar GopalChestnut Hill$5K
- Allan GoldsteinBoston$962K
- Michael PlattBoston$753K
- Avner AliphasNewton$735K
- Christopher BrookBoston$734K
- Gregory RandolphBoston$550K
- Ayesha KhalidConcord$511K
- Aiden ShearerBoston$444K
- Dennis PoeBoston$264K
- Phillip HuyettBoston$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.